This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Kenvue Brands Llc/inria (Institut National De Recherche En Informatique Et En Automatique). Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Imane Lboukili: Innovator in Epithelial Tissue Analysis
Introduction
Imane Lboukili is a notable inventor based in Val de Reuil, France. She has made significant contributions to the field of biomedical engineering, particularly in the analysis and characterization of epithelial tissue structures. Her innovative work focuses on developing methods for non-invasive or minimally invasive assessments of epithelial tissue.
Latest Patents
Imane holds a patent for her invention titled "Analysis and characterization of epithelial tissue structure." This patent discloses methods that utilize digital imaging and processing to identify cell locations within epithelial tissues. More specifically, it describes an automated algorithm designed to identify epithelial tissue structures and specify the coordinates of cells through non-invasive imaging techniques. This groundbreaking approach allows for the extraction of values related to epithelial structure parameters.
Career Highlights
Imane Lboukili is currently associated with Kenvue Brands LLC and Inria (Institut National De Recherche En Informatique Et En Automatique). Her work at these institutions has allowed her to collaborate with leading experts in the field and contribute to advancements in medical imaging and tissue analysis.
Collaborations
Some of her notable coworkers include Georgios N Stamatas and Thierry Oddos. Their collaborative efforts have further enhanced the research and development of innovative solutions in the biomedical sector.
Conclusion
Imane Lboukili's contributions to the analysis of epithelial tissue structures exemplify her commitment to innovation in biomedical engineering. Her work not only advances scientific understanding but also has the potential to improve medical diagnostics and patient care.